Former Juno execs unveil Sana, a new cell engineering biotech that’s reportedly raising more than $800M by James Thorne on January 7, 2019February 15, 2019 at 8:43 am Former Juno Therapeutics executives Hans Bishop and Steve Harr have launched Sana Biotechnology, a startup focused on cell therapy, gene therapy and gene editing. Backed by ARCH Venture Partners, Flagship… Read More